Erythropoiesis, red cells, and the approach to anemia

Neonatal Hematology

Volumn , Issue , 2005, Pages 40-57

  de Alarcón, Pedro A ^a   Johnson, M Cris ^b   Werner, Eric J ^c  

^a St Jude Children s Research Center   (United States)

^b CHILDREN S HOSPITAL CENTRAL CALIFORNIA   (United States)

^c Children's Hospital of The King's Daughters   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954570493     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545306.005     Document Type: Chapter

References (115)

1. Till, J. E., McCulloch, E.A.Adirectmeasurement Of theradi- ationsensitivityof normalmousebonemarrowcells. Radiat Res 1961;14:213-222.
2. Bradley, J. R., Metcalf, D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci 1966; 44: 287-300.
3. Moore, M. A., Williams, N., Metcalf, D.Invitrocolonyforma-tion by normal and leukemic human hematopoietic cells: characterization of the colony-forming cells. J Natl Cancer Inst 1973; 50: 603-623.
4. Nakahata, T., Tsuji, K., Ishiguro, A., et al. Single-cell origin of human mixed hemopoietic colonies expressing various combinations of cell lineages. Blood 1985; 65:1010-1016.
5. Stephenson, J. R., Axelrad, A. A., McLeod, D. L., Shreeve, M. M. Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro. Proc Natl Acad Sci USA 1971; 68: 1542-1546.
6. Suda, T., Suda, J., Ogawa, M. Single-cell origin of mouse hemopoietic colonies expressing multiple lineages in variable combinations. Proc Natl Acad Sci USA 1983; 80: 6689-6693.
7. Metcalf, D. Stem cells, pre-progenitor cells and lineage- committed cells: are our dogmas correct? Ann N Y Acad Sci 1999; 872: 289-303, 303-304.
8. Fisher, J. W. Erythropoietin: physiology and pharmacology update. Exp Biol Med 2003; 228: 1-14.
9. Wyrsch, A., dalle Carbonare, V., Jansen, W., et al. Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity. Exp Hematol 1999; 27:1338-1345.
10. Shannon, K. M., Naylor, G. S., Torkildson, J. C., etal. Circulating erythroid progenitors in the anemia of prematurity. NEngl J Med 1987; 317: 728-733.
11. Palis, J., Robertson, S., Kennedy, M., Wall, C., Keller, G. Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development 1999; 126: 5073-5084.
12. Keller, G., Lacaud, G., Robertson, S. Development of the hematopoietic system in the mouse. Exp Hematol 1999; 27: 777-787.
13. Palis, J., Yoder, M. C. Yolk-sac hematopoiesis: the first blood cells of mouse and man. Exp Hematol 2001; 29: 927-936.
14. Dieterlen-Lievre, F., Pardanaud, L., Bollerot, K., Jaffredo, T. Hemangioblasts and hemopoietic stem cells during ontogeny. CRBiol 2002; 325:1013-1020.
15. Jaffredo, T., Gautier, R., Brajeul, V., Dieterlen-Lievre, F. Tracing the progeny of the aortic hemangioblast in the avian embryo. DevBiol 2000; 224: 204-214.
16. Jaffredo, T., Gautier, R., Eichmann, A., Dieterlen-Lievre, F. Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny. Development 1998; 125: 4575-4583.
17. Dieterlen-Lievre, F., Godin, I., Pardanaud, L. Where do hematopoietic stem cells come from? Int Arch Allergy Immunol 1997; 112: 3-8.
18. Kelemen E, Calvo, W., Fliedner, T. M. Atlas of Human Hematopoietic Development.Berln, Springer-Verlag, 1979.
19. Emura, I., Sekiya, M., Ohnishi, Y. Ultrastructural identification of the hemopoietic inductive microenvironment in the human embryonic liver. Arch Histol Jpn 1984; 47: 95-112.
20. Emura, I., Sekiya, M., Ohnishi, Y. Four types of presumptive hemopoietic stem cells in the human fetal liver. Arch Histol Jpn 1983; 46: 645-662.
21. Emura, I., Sekiya, M., Ohnishi, Y. Two types of immature erythrocytic series in the human fetal liver. Arch Histol Jpn 1983; 46: 631-643.
22. Fukuda, T. Fetal hemopoiesis. I. Electron microscopic studies on human yolk sac hemopoiesis. Virchows Arch B Cell Pathol 1973; 14:197-213.
23. Zamboni, L. Electron microscopic studies of bloodembryo- genesis in humans. II. The hemopoietic activity in the fetal liver. J Ultrastruct Res 1965; 12: 525-541.
24. Gilmour, J. R. Normal haemopoiesis in intra-uterine and neonatal life. J Pathol 1941; 52:25-55.
25. Eichmann, A., Corbel, C., Nataf, V, etal. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc Natl Acad Sci USA 1997; 94:5141-5146.
26. Takashina, T. Haemopoiesis in the human yolk sac. J Anat 1987; 151:125-35.
27. Fukuda, T. Fetal hemopoiesis. II. Electron microscopic studies on human hepatic hemopoiesis. Virchows Arch B Cell Pathol 1974; 16: 249-270.
28. Moore, M. A., Metcalf, D. Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br J Haematol 1970; 18: 279-296.
29. Delassus, S., Titley, I., Enver, T. Functional and molecular analysis of hematopoietic progenitors derived from the aorta-gonad-mesonephros region of the mouse embryo. Blood 1999; 94:1495-1503.
30. Yoder, M. C., Cumming, J. G., Hiatt, K., Mukherjee, P., Williams, D. A. A novel method of myeloablation to enhance engraftment of adult bone marrow cells in newborn mice. Biol Blood Marrow Transplant 1996; 2:59-67.
31. Yoder, M. C., Hiatt, K. Engraftment of embryonic hematopoietic cells in conditioned newborn recipients. Blood 1997; 89: 2176-2183.
32. Stockman, J. A., Pochedly, C. Developmental and Neonatal Hematology. New York: Raven Press, 1988.
33. Lee, G. R., Foerster, J., Lukens, J., et al. Wintrobe’s Clinical Hematology, 10th edn. Philadelphia: Lippincott Williams & Wilkins, 1999.
34. Nathan, D. G., Orkin, S. H. Hematology of Infancy and Childhood, 5th edn. Philadelphia: W. B. Saunders Co., 1998.
35. Gross, G. P, Hathaway, W. E. Fetal erythrocyte deformability Pediatr Res 1972; 6: 593-599.
36. Tillman, W., Wagner, D., Schroter, W. Decreased flexibility of newborn infant erythrocytes. Blut 1977; 34:281-288.
37. Buchan, P C. Evaluation and modification of whole blood filtration in the measurement of erythrocyte deformability in preganacy and the newborn. Br J Haematol 1980; 45:97105.
38. Landaw, S. A., Rathbun, S. C., Guancial, R. L. Evidence for a tightly linked spectrin lattice in red blood cells of new-bornman. Prog Soc Pediatr Res 1982; 16 (2): 208A, abstract 776.
39. Neerhout, R. C. Erythrocyte lipids in the neonate. Pediatr Res 1968; 2: 172-178.
40. Crowley, J., Ways, P., Jones, J. W. Human fetal erythrocyte and plasma lipids. J Clin Invest 1965; 44:989-998.
41. Delaunay, J. Red cell membrane and erythropoiesis genetic defects. Hematol J 2003; 4 (4): 225-232.
42. Hoffman, R. Hematology: Basic Principles and Practice, 3rd edn. New York: Churchill Livingstone, 2000.
43. Oski, F. A., Naiman, J. L. Red cell metabolism in the premature infant. I. Adenosine triphosphate levels, adenosine triphosphate stability and glucose consumption. Pediatrics 1965; 36:104-112.
44. Ng, W. G., Bergren, W. R., Donnell, G. N., Hodgman, J. E., et al. Galactose-1 phosphate uridyl transferase activity in hemolysates of newborn infants. Pediatrics 1967; 39 (2): 293-294.
45. Travis, S. F., Kumar, S. P, Paez, P. C., Delivoria-Papadopoulous, M.Redcellmetabolicalterationsandpost-natal life interm infants: glycolytic enzymes and glucose-6-phosphatedehydrogenase.PediatrRes 1980;14:1349-1352.
46. Konrad, P N., Valentine, W. N., Paglia, D. E. Enzymatic activi- tiesandglutathionecontentof erythrocytesinthenewborn: comparison with red cells of older subjects and those with comparable reticulocytosis. Acta Haematol 1972; 48: 193.
47. Gross, R. T., Schroeder, E. A., Brounstein, S. A. Energy metabolism in the erythrocytes of premature infants compared to full term newborn infants and adults. Blood 1963; 21:755-765.
48. Whittam, R. Control of membrane permeability to potassium in red blood cells. Nature 1968; 219 (154): 610.
49. Stave, U., Hintz, H. On erythrocytes in newborn infants. Hematological and enzymological studies in the 1st year of life. Z Kinderheinkd 1961; 86:184-197.
50. De Luca, C., Stevenson, J. H., Jr, Kaplan, E. Simultaneous multiple-column chromatography: its application to the separation of the adenine nucleotides of human erythrocytes. Anal Biochem 1962; 4: 39-45.
51. Schroter, W., Tillman, W. Heinz body susceptibility of red cells and exchange transfusion. Acta Haematol 1973; 49:7479.
52. Tillman, W., Menke, J., Schroter, W. The formation of Heinz bodies in ghosts of human erythrocytes of adults and newborn infants. Clin Wochenschr 1973; 51: 201-203.
53. Stockman, J. A., Clark, D. A. Diminished antioxidant activity of newborninfants.Pediatr Res 1981;15:684.Abstract1444.
54. Carrell, R. W., Winterbourn, C. C., Rachmilewitz, E. A. Activated oxygen and hemolysis. Br J Haematol 1975; 30: 259-264.
55. Stockman, J. A. Newborn red cells, the nature of oxidant injury. Pediatr Res 1977; 11: 41.
56. Bunn, H. F. Human hemoglobins: normal and abnormal. In Nathan, D. G., Orkin, S. H., eds. Hematology of Infancy and Childhood, 5th edn. Philadelphia: W. B. Saunders Co., 1998: 729-762.
57. Hann, I.M. The normalblood picture in neonates. In Hann, M., Gibson, B.E.S., Letsky, E.A., eds. Fetal and Neonatal Hematology. London: Bailliere Tindall, 1991: 29-50.
58. Stockman, J. A., 3rd, Garcia, J. F., Oski, F. A. The anemia of prematurity. Factors governing the erythropoietin response. N Engl J Med 1977; 296: 647-650.
59. Delivoria-Papadopoulos, M., Roncevic, N. P., Oski, F.A. Postnatal changes in oxygen transport of term, preterm and sick infants: the role of red cell 2, 3-diphosphoglycerate and adult hemoglobin. Pediatr Res 1971; 5: 235-245.
60. Bifano, E.M., Smith, F., Borer, J. Relationship between determinants of oxygen delivery and respiratory abnormalities in preterm infants with anemia. J Pediatr 1992; 120: 292-296.
61. Izraeli, S., Ben-Sira, L., Harell, D., et al. Lactic acid as a predictor for erythrocyte transfusion in healthy preterm infants with anemiaof prematurity. J Pediatr 1993; 122:629631.
62. Stockman, J. A., 3rd, Clark, D. A. Weight gain: a response to transfusion in selected preterm infants. Am J Dis Child 1984; 138: 828-830.
63. Delivoria-Papadopoulos, M., Roncevic, N. P, Oski, F. A. Postnatal changes in oxygen transport of term, preterm and sickinfants: the role of red cell 2, 3-diphosphoglycerate and adult hemoglobin. Pediatr Res 1971; 5: 235-245.
64. Forestier, F., Daffos, F., Glacteros, F., et al. Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res 1986; 20: 342-346.
65. Saltzman, D. H., Frigoletto, F. D., Harlow, B. L., Barss, V A., Benacerraf, B. R. Sonographic evaluation of hydrops fetalis. Obstet Gynecol 1989; 74: 106-111.
66. Burman, D., Morris, A. F. Cord haemoglobin in low birth- weight infants. Arch Dis Child 1974; 49: 382-385.
67. Rivera, L. M., Rudolph, N. Postnatal persistence of capillary- venous differences in hematocrit and hemoglobin values in low-birth-weight and term infants. Pediatrics 1982; 70:956-957.
68. Thurlbeck, S. M., McIntosh, N. Preterm blood counts vary with sampling site. Arch Dis Child 1987; 62:74-75.
69. Stockman, J. A., III, Oski, F. A. Physiological anaemia of infancy and the anaemia of prematurity. Clin Haematol 1978;7:3-18.
70. O’Brien, R. T., Pearson, H. A. Physiologic anemiaof the newborn infant. J Pediatr 1971; 79:132-138.
71. Stockman, J. A., III, Garcia, J. F., Oski, F.A.Theanemiaof pre- maturity: factors governing the erythropoietin response. N Engl J Med 1977; 296: 647-650.
72. Lin, J. C., Strauss, R. G., Kulhavy, J. C., et al. Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics 2000; 106: E19.
73. Stockman, J. A., III, de Alarcon, P. A. Overview Of thestate of the art of Rh disease: history, current clinical management, and recent progress. J Pediatr Hematol Oncol 2001; 23:385-393.
74. Hariharan, D., Manno, C. S., Seri, I. Neonatal lupus erythematosus with microvascular hemolysis. J Pediatr Hematol Oncol 2000; 22: 351-354.
75. Passi, G. R., Kriplani, A., Pati, H. P, Choudhry, V P. Isoimmune hemolysis in an infant due to maternal Evans’ syndrome. Indian J Pediatr 1997; 64: 893-895.
76. Sokol, R. J., Hewitt, S., Stamps, B. K. Erythrocyte autoantibodies, autoimmune haemolysis and pregnancy. Vox Sang 1982; 43:169-176.
77. Sacks, D. A., Platt, L. D., Johnson, C. S. Autoimmune hemolytic disease during pregnancy. Am J Obstet Gynecol 1981; 140: 942-946.
78. Kitzmiller, J. L. Autoimmune disorders: maternal, fetal, and neonatal risks. Clin Obstet Gynecol 1978; 21: 385-396.
79. Chaplin, H., Jr, Cohen, R., Bloomberg, G., et al. Pregnancy and idiopathic autoimmune haemolytic anaemia: a prospective study during 6 months gestation and 3 months post-partum. Br J Haematol 1973; 24: 219-229.
80. Baumann, R., Rubin, H. Autoimmune hemolytic anemia during pregnancy with hemolytic disease in the newborn. Blood 1973;41:293-297.
81. Gilsanz, F., Vega, M. A., Gomez-Castillo, E., Ruiz-Balda, J.A., Omenaca, F. Fetal anaemia due to pyruvate kinase deficiency. Arch Dis Child 1993; 69: 523-524.
82. Hennekam, R. C., Beemer, F. A., Cats, B. P., Jansen, G., Staal, G. E. Hydropsfetalisassociatedwithredcellpyruvatekinase deficiency. Genet Couns 1990; 1: 75-79.
83. Whitelaw, A. G., Rogers, P. A., Hopkinson, D. A., et al. Congenital haemolytic anaemia resulting from glucose phosphate isomerase deficiency: genetics, clinical picture, and prenatal diagnosis. J Med Genet 1979; 16: 189-196.
84. Gallagher, P G., Petruzzi, M. J., Weed, S. A., et al. Mutation of a highly conserved residue of betaI spectrin associated with fatal and near-fatal neonatal hemolytic anemia. J Clin Invest 1997; 99: 267-277.
85. Gallagher, P G., Weed, S. A., Tse, W. T., et al. Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte beta-spectrin gene. J Clin Invest 1995; 95: 1174-1182.
86. Whitfield, C. F., Follweiler, J. B., Lopresti-Morrow, L., Miller, B. A. Deficiency of alpha-spectrin synthesis in burstforming units-erythroid in lethal hereditary spherocytosis. Blood 1991; 78: 3043-3051.
87. Delhommeau, F., Cynober, T., Schischmanoff, P. O., et al. Natural history of hereditary spherocytosis during the first year of life. Blood 2000; 95: 393-397.
88. Kaplan, M., Hammerman, C. Glucose-6-phosphate dehydrogenase deficiency: apotential source of severe neonatal hyperbilirubinaemia and kernicterus. Semin Neonatol 2002; 7: 121-128.
89. Herschel, M., Ryan, M., Gelbart, T., Kaplan, M. Hemolysis and hyperbilirubinemia in an African American neonate heterozygous for glucose-6-phosphate dehydrogenase deficiency. J Perinatol 2002; 22: 577-579.
90. Kaplan, M., Abramov, A. Neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency in Sephardic-Jewish neonates: incidence, severity, and the effect of phototherapy. Pediatrics 1992; 90: 401-405.
91. Lu, T. C., Wei, H., Blackwell, R. Q. Increased incidence of severe hyperbilirubinemia among newborn Chinese infants with G-6-P D deficiency. Pediatrics 1966; 37: 994-999.
92. Missiou-Tsagaraki, S. Screening for glucose-6-phosphate dehydrogenase deficiency as a preventive measure: prevalence among 1, 286, 000 Greek newborn infants. J Pediatr 1991; 119: 293-299.
93. Kaplan, M., Renbaum, P., Levy-Lahad, E., et al Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci USA 1997; 94: 12128-12132.
94. Slusher, T. M., Vreman, H. J., McLaren, D. W., etal. Glucose-6-phosphate dehydrogenase deficiency and carboxyhe- moglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants. J Pediatr 1995; 126: 102-108.
95. Kaplan, M., Hammerman, C., Vreman, H. J., Stevenson, D. K., Beutler, E. Acute hemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase- deficient heterozygotes. J Pediatr 2001; 139:137-140.
96. Sarihan, H., Mocan, H., Abeys, M., etal. Kasabach-Merrit syndrome in infants. Panminerva Med 1998; 40: 128-131.
97. Bjerke, H. S., Kelly, R. E. J., Foglia, R. P., Barcliff, L., Petz, L. Decreasingtransfusionexposureriskduringextracorporeal membrane oxygenation (ECMO). Transfus Med 1992; 2:4349.
98. Sartori, P. C., Enayat, M. S., Darbyshire, P. J. Congenital microangiopathic haemolytic anemia: a variant of thrombotic thrombocytopenic purpura? Pediatr Hematol Oncol 1993; 10: 271-277.
99. Kling, P. J., Schmidt, R. L., Roberts, R. A., Widness, J. A. Serum erythropoietin levels during infancy: associations with erythropoiesis. J Pediatr 1996; 128: 791-796.
100. Kanto, W. P., Jr, Marino, B., Godwin, A. S., Bunyapen, C.ABO hemolytic disease: a comparative study of clinical severity and delayed anemia. Pediatrics 1978; 62: 365-369.
101. Strand, C., Polesky, H. F. Delayed anemiain erythroblastosis fetalis. Minn Med 1972; 55: 439-441.
102. Scaradavou, A., Inglis, S., Peterson, P., et al. Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia. J Pediatr 1993; 123: 279-284.
103. Ohls, R. K., Hunter, D. D., Christensen, R. D. A randomized, double-blind, placebo-controlled trial of recombinant erythropoietin in treatment of the anemia of bronchopulmonary dysplasia. J Pediatr 1993; 123: 996-1000.
104. Christensen, R. D., Hunter, D. D., Goodell, H., Rothstein, G. Evaluation of the mechanism causing anemia in infants with bronchopulmonary dysplasia. JPediatr 1992; 120:593-598.
105. Sood, S. K., Ramachandran, K., Mathur, M., et al. W.H.O. sponsored collaborative studies on nutritional anaemia in India. 1. The effects of supplemental oral iron administration to pregnant women. QJ Med 1975; 44: 241-258.
106. Chan, S., Gerson, B., Subramaniam, S. The role of copper, molybdenum, selenium, and zinc in nutrition and health. Clin Lab Med 1998; 18: 673-685.
107. Oski, F. A. Nutritional anemias. Semin Perinatol 1979; 3: 381-395.
108. Ashkenazi, A., Levin, S., Djaldetti, M., Fishel, E., Benvenisti, D. The syndrome of neonatal copper deficiency. Pediatrics 1973; 52: 525-533.
109. Karpel, J. T., Peden, V. H. Copper deficiency in long-term parenteral nutrition. J Pediatr 1972; 80:32-36.
110. Krasinski, K., Perkin, R., Rutledge, J. Gray baby syndrome revisited. Clin Pediatr (Phila) 1982; 21: 571-572.
111. Stahl, M. M., Neiderud, J., Vinge, E. Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J Pediatr 1997; 130: 1001-1003.
112. Ramaekers, L. H., The, T. S. Maternal anticonvulsants and perinatal risk. Eur JObstet Gynecol Reprod Biol 1975;5:277-282.
113. Widness, J. A., Seward, V. J., Kromer, I. J., etal. Changingpat-terns of red blood cell transfusion in very low birth weight infants. J Pediatr 1996; 129: 680-687.
114. Fain, J., Hilsenrath, P., Widness, J. A., Strauss, R. G., Mut-nick, A. H. A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity. Transfusion 1995; 35: 936-943.
115. Stockman, J. A., III.Anemia in children. Differential Insight 1979; 1:13-20.